Coastal Investment Advisors, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Coastal Investment Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$48.35 - $118.68 $5,076 - $12,461	-105 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$57.36 - $124.1 $4,302 - $9,307	-75 Reduced 41.67%	105 $11,000
Q3 2019 Oct 18, 2019	SELL	$58.69 - $80.46 $72,599 - $99,529	-1,237 Reduced 87.3%	180 $12,000
Q2 2019 Aug 01, 2019	BUY	$77.77 - $120.68 $61,204 - $94,975	787 Added 124.92%	1,417 $112,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $57,852 - $76,028	630 New	630 $70,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.